525 related articles for article (PubMed ID: 26711738)
1. Prevalence and Prognostic Significance of Apparent Treatment Resistant Hypertension in Chronic Kidney Disease: Report From the Chronic Renal Insufficiency Cohort Study.
Thomas G; Xie D; Chen HY; Anderson AH; Appel LJ; Bodana S; Brecklin CS; Drawz P; Flack JM; Miller ER; Steigerwalt SP; Townsend RR; Weir MR; Wright JT; Rahman M;
Hypertension; 2016 Feb; 67(2):387-96. PubMed ID: 26711738
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Apparent Therapy-Resistant Hypertension and Its Effect on Outcome in Patients With Chronic Kidney Disease.
de Beus E; Bots ML; van Zuilen AD; Wetzels JF; Blankestijn PJ;
Hypertension; 2015 Nov; 66(5):998-1005. PubMed ID: 26351024
[TBL] [Abstract][Full Text] [Related]
3. Treatment-resistant hypertension and the incidence of cardiovascular disease and end-stage renal disease: results from the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Muntner P; Davis BR; Cushman WC; Bangalore S; Calhoun DA; Pressel SL; Black HR; Kostis JB; Probstfield JL; Whelton PK; Rahman M;
Hypertension; 2014 Nov; 64(5):1012-21. PubMed ID: 25259745
[TBL] [Abstract][Full Text] [Related]
4. Resistant Hypertension, Time-Updated Blood Pressure Values and Renal Outcome in Type 2 Diabetes Mellitus.
Viazzi F; Piscitelli P; Ceriello A; Fioretto P; Giorda C; Guida P; Russo G; De Cosmo S; Pontremoli R;
J Am Heart Assoc; 2017 Sep; 6(9):. PubMed ID: 28939716
[TBL] [Abstract][Full Text] [Related]
5. Inflammation and Apparent Treatment-Resistant Hypertension in Patients With Chronic Kidney Disease.
Chen J; Bundy JD; Hamm LL; Hsu CY; Lash J; Miller ER; Thomas G; Cohen DL; Weir MR; Raj DS; Chen HY; Xie D; Rao P; Wright JT; Rahman M; He J
Hypertension; 2019 Apr; 73(4):785-793. PubMed ID: 30776971
[TBL] [Abstract][Full Text] [Related]
6. Prevalence, phenotypic characteristics and prognostic role of apparent treatment resistant hypertension in the German Chronic Kidney Disease (GCKD) study.
Mielke J; Trucks-Jansen H; Schurmann C; Kotsis F; Köttgen A; Schneider MP; Eckardt KU; ; Freitag DF; Eitner F; Becker MS
J Hum Hypertens; 2023 May; 37(5):345-353. PubMed ID: 35534618
[TBL] [Abstract][Full Text] [Related]
7. Prediction of cardiovascular and renal risk among patients with apparent treatment-resistant hypertension in the United States using machine learning methods.
Bakris G; Lin PP; Xu C; Chen C; Ashton V; Singhal M
J Clin Hypertens (Greenwich); 2024 May; 26(5):500-513. PubMed ID: 38523465
[TBL] [Abstract][Full Text] [Related]
8. Chronic kidney disease and incident apparent treatment-resistant hypertension among blacks: Data from the Jackson Heart Study.
Tanner RM; Shimbo D; Irvin MR; Spruill TM; Bromfield SG; Seals SR; Young BA; Muntner P
J Clin Hypertens (Greenwich); 2017 Nov; 19(11):1117-1124. PubMed ID: 28921875
[TBL] [Abstract][Full Text] [Related]
9. Apparent treatment-resistant hypertension and chronic kidney disease: another cardiovascular-renal syndrome?
Vemulapalli S; Tyson CC; Svetkey LP
Adv Chronic Kidney Dis; 2014 Nov; 21(6):489-99. PubMed ID: 25443574
[TBL] [Abstract][Full Text] [Related]
10. Prevalence and clinical characteristics of apparent therapy-resistant hypertension in patients with cardiovascular disease: a cross-sectional cohort study in secondary care.
de Beus E; van der Sande NGC; Bots ML; Spiering W; Voskuil M; Visseren FLJ; Blankestijn PJ
BMJ Open; 2017 Sep; 7(9):e016692. PubMed ID: 28882918
[TBL] [Abstract][Full Text] [Related]
11. Apparent treatment-resistant hypertension and risk for stroke, coronary heart disease, and all-cause mortality.
Irvin MR; Booth JN; Shimbo D; Lackland DT; Oparil S; Howard G; Safford MM; Muntner P; Calhoun DA
J Am Soc Hypertens; 2014 Jun; 8(6):405-13. PubMed ID: 24952653
[TBL] [Abstract][Full Text] [Related]
12. Cardiovascular and mortality risk of apparent resistant hypertension in women with suspected myocardial ischemia: a report from the NHLBI-sponsored WISE Study.
Smith SM; Huo T; Delia Johnson B; Bittner V; Kelsey SF; Vido Thompson D; Noel Bairey Merz C; Pepine CJ; Cooper-Dehoff RM
J Am Heart Assoc; 2014 Feb; 3(1):e000660. PubMed ID: 24584740
[TBL] [Abstract][Full Text] [Related]
13. Prevalence of optimal treatment regimens in patients with apparent treatment-resistant hypertension based on office blood pressure in a community-based practice network.
Egan BM; Zhao Y; Li J; Brzezinski WA; Todoran TM; Brook RD; Calhoun DA
Hypertension; 2013 Oct; 62(4):691-7. PubMed ID: 23918752
[TBL] [Abstract][Full Text] [Related]
14. Apparent Treatment Resistant Hypertension, Blood Pressure Control and the Progression of Chronic Kidney Disease in Patients with Type 2 Diabetes.
Viazzi F; Greco E; Ceriello A; Fioretto P; Giorda C; Guida P; Russo G; De Cosmo S; Pontremoli R;
Kidney Blood Press Res; 2018; 43(2):422-438. PubMed ID: 29698970
[TBL] [Abstract][Full Text] [Related]
15. Resistant hypertension and cardiovascular disease mortality in the US: results from the National Health and Nutrition Examination Survey (NHANES).
Kaczmarski KR; Sozio SM; Chen J; Sang Y; Shafi T
BMC Nephrol; 2019 Apr; 20(1):138. PubMed ID: 31023262
[TBL] [Abstract][Full Text] [Related]
16. Real-World Impact of Blood Pressure Control in Patients With Apparent Treatment-Resistant or Difficult-to-Control Hypertension and Stages 3 and 4 Chronic Kidney Disease.
Bakris G; Chen C; Campbell AK; Ashton V; Haskell L; Singhal M
Am J Hypertens; 2024 May; 37(6):438-446. PubMed ID: 38436491
[TBL] [Abstract][Full Text] [Related]
17. Reassessment of Ambulatory Blood Pressure Improves Renal Risk Stratification in Nondialysis Chronic Kidney Disease: Long-Term Cohort Study.
Minutolo R; Gabbai FB; Chiodini P; Garofalo C; Stanzione G; Liberti ME; Pacilio M; Borrelli S; Provenzano M; Conte G; De Nicola L
Hypertension; 2015 Sep; 66(3):557-62. PubMed ID: 26150434
[TBL] [Abstract][Full Text] [Related]
18. Long-term trajectory of renal dysfunction and related risk factors in patients with apparently treatment-resistant and non-resistant arterial hypertension.
Ramík Z; Václavík J; Kvapil T; Jelínek L; Kociánová E; Kamasová M; Benešová K; Jarkovský J; Drápela M; Lys Z
Blood Press; 2024 Dec; 33(1):2353836. PubMed ID: 38847517
[TBL] [Abstract][Full Text] [Related]
19. Current antihypertensive treatment and treatment-resistant hypertension in Japanese patients with chronic kidney disease.
Tsuchimoto A; Tanaka S; Kitamura H; Hiyamuta H; Tsuruya K; Kitazono T; Nakano T;
Clin Exp Nephrol; 2022 Nov; 26(11):1100-1110. PubMed ID: 35927602
[TBL] [Abstract][Full Text] [Related]
20. Prevalence, Predictors, and Outcomes of Pulmonary Hypertension in CKD.
Navaneethan SD; Roy J; Tao K; Brecklin CS; Chen J; Deo R; Flack JM; Ojo AO; Plappert TJ; Raj DS; Saydain G; Sondheimer JH; Sood R; Steigerwalt SP; Townsend RR; Dweik RA; Rahman M;
J Am Soc Nephrol; 2016 Mar; 27(3):877-86. PubMed ID: 26386072
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
